AJMB-Avicenna Journal of Medical Biotechnology. 2018; 10 (3): 152-157
en Inglés
| IMEMR
| ID: emr-202057
ABSTRACT
Background:
Hepatitis C [HCV] is known as a serious blood-borne disease that infects millions of people globally. NS3 is a conserved non-structural sequence of hepatitis C virus which has a major role in activating specific CTL responses. As known, there is no effective vaccine against HCV infection, thus it is required to design a specific regimen of vaccination. Recently, the strong immunological properties of Heat shock proteins [Hsps] led to their use as immunomodulators and an antigen carrier for subunit vaccine candidates. In the current study, the role of Hsp20 was evaluated as a HCV NS3 gene carrier in mammalian cell line
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Avicenna J. Med. Biotechnol.
Año:
2018
Similares
MEDLINE
...
LILACS
LIS